Hospitals in Abu Dhabi and Dubai expand AI use in patient care

Hospitals in Abu Dhabi and Dubai are expanding their use of artificial intelligence in patient care, a move that reflects accelerating AI adoption across frontline healthcare in the UAE. The development signals near-term effects for clinical practice, purchasing decisions and regulatory work in the region.

Reported expansion of AI use in these hospitals touches clinical workflows and is likely to affect procurement decisions, create vendor opportunities and influence patient outcomes, while also raising questions for regulators overseeing health services. Observers see this as both a market and policy story with implications for health providers, technology firms and regulators.

For health providers, adopting AI tools will require planning for integration into existing care pathways, staff training, and attention to data governance and quality. Successful deployment depends on careful change management, monitoring of clinical effects and alignment with organisational goals for patient safety and outcomes.

Technology firms stand to gain clearer commercial opportunities as hospitals expand AI use, but they will need to prioritise validation, interoperability and evidence of benefit to win procurement rounds. Vendors that can demonstrate safety, measurable impact and readiness for integration will be better positioned in the evolving market.

Regulators and policymakers will face decisions about standards, validation pathways and governance mechanisms to ensure AI is safe and effective for patients. The expansion of AI in patient care raises questions over reporting requirements, transparency, and accountability that authorities may need to resolve promptly.

Monitor adoption: track real-world use and clinical impact as AI tools are introduced.

• Prepare procurement: update criteria to require validation, interoperability and measurable outcomes

Invest in training: equip clinical and IT teams to integrate and manage AI systems safely.

• Engage regulators: work proactively with authorities on standards, reporting and governance

Prioritize patients: focus procurement and deployment on demonstrable benefits for patients' safety and outcomes.

Health providers, technology companies and regulators in the UAE should monitor developments closely, update procurement and governance practices, invest in staff readiness, and focus on measurable patient benefit as AI is rolled out in care settings.

The expansion was reported by Arabian Business

As organisations navigate AI change, Nuvostella helps teams put practical AI systems to work — from generative tools and agents to automation built for real business processes.

Resources & links

• Arabian Business — Abu Dhabi and Dubai hospitals expand AI in patient care
• Nuvostella Generative Studio